Trials / Completed
CompletedNCT03996226
A Food-Effect Study of E7386 in Healthy Participants
A Phase 1 Food-Effect Study of E7386 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to determine the effect of food in healthy participants on the bioavailability of E7386 following single dose administration with and without a meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E7386 | E7386 oral tablets. |
Timeline
- Start date
- 2019-06-07
- Primary completion
- 2019-10-29
- Completion
- 2019-10-29
- First posted
- 2019-06-24
- Last updated
- 2019-11-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03996226. Inclusion in this directory is not an endorsement.